Krishna Tripuraneni, MD
Adult Reconstructive Orthopaedic Surgery · Albuquerque, NMNPI 1558400572
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,063 of the $59,747 with a category attached, or 77.1%. Exactech, Inc. accounts for 65.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $21,061 and has fallen 87.5% since, to $2,625 in 2025.
Across 134 payments — averaging $445.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$39K
- Zimmer Biomet$17K
- Stryker$2K
- Smith+Nephew$387
- Johnson & Johnson$192
- DJO, LLC$16
- plus $14 from 1 others
Across 116 payments — averaging $5007.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$581K
What the payments were for
- Consulting fees$46,06377%
- Travel & lodging$8,25114%
- Food & beverage$5,4349%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 35 | $39,232 |
| Zimmer Biomet | 62 | $17,445 |
| Stryker | 25 | $2,461 |
| Smith+Nephew | 6 | $387 |
| Johnson & Johnson | 4 | $192 |
| DJO, LLC | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRULIANT$36,869
- PD-Knee-New Product$9,670
- MAKO$1,928
- Avenir$1,479
- EQUINOXE$1,434
- Connected Health Product Portfolio$1,231
- Persona$1,010
- OPTETRAK$500
- ROSA$414
- mymobility Platform$148
- EVOS$129
- Persona Revision$125
- TRIGEN Meta-Nail$123
- Synovasure$122
- Toggleloc$116
- EXACTECHGPS$115
How this compares
Too few adult reconstructive orthopaedic surgery providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 55 | $907 |
| Oxycodone Hcl | 35 | $262 |
| Methylprednisolone | 30 | $258 |
| Tramadol Hcl | 28 | $142 |
| Cephalexin | 13 | $125 |
| Gabapentin | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Albuquerque
- Joshua CarothersAlbuquerque$9K
- Mark WernerAlbuquerque$2K
- James NinomiyaAlbuquerque$320
- Ugonna EzehLas Cruces$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.